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Abstract. In spite of the improved outcome of orthotopic 
liver transplantation (OLTx), primary graft nonfunction 
remains one of the life-threatening problems following 
OLTx. The purpose of this study was to evaluate plasma 
lecithin: cholesterol acyltransferase (LCAT) activity in 
mUltiple organ donors as a predictor of liver allograft via-
bility prior to OLTx. Thirty-nine donors were studied dur-
ing a 5-month period between April and August 1988. 
Allograft hepatectomy was performed using a rapid 
technique or its minor modification with hilar dissections, 
and the allografts were stored cold (4 "C) in University of 
Wisconsin (UW) solution. Early post-transplant allograft 
function was classified as good, fair, or poor, according to 
the highest SGOT, SGPT, and prothrombin time within 
5 days following OLTx. Procurement records were re-
viewed to identify donor data, which included conven-
tionalliver function tests, duration of hospital stay, history 
of cardiac arrest, and graft ischemic time. Blood samples 
from the donors were drawn immediately prior to aortic 
crossclamp, and from these plasma LCAT activity was 
determined. Plasma LCAT activity of all donors was sig-
nificantly lower than that of healthy controls (12.4 ± 8.0 
vs 39.2 ± 13.3 Ilg/ml per hour, P < 0.01). LCAT activity 
(16.4 ± 8.3 Ilg/ml per hour) in donors of grafts with good 
function was significantly higher than that in those with fair 
(8.6 ± 4.5 Ilglml perhour,P < 0.01) or poor (7.3 ± 2.4llg/ml 
per hour, P < 0.01) function. Information regarding pro-
curement, which was complete in the records of 31 of 39 
donors, was used in a multiple logistic regression analysis 
that revealed plasma LCAT activity to be the only factor 
able to discriminate the quality of the hepatic graft from 
other variables in multiple organ donors. The present study 
suggests that the determination of plasma LCAT activity 
in multiple organ donors is extremely useful for the assess-
ment of hepatic allograft viability prior to OLTx. 
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In spite of the recent introduction of University of Wis-
consin (UW) solution, which now allows safe preservation 
of hepatic allografts for up to 24 h [6,20], the shortage of 
donor livers continues to be one of the major limiting fac-
tors for clinical liver transplantation. Immediate function 
of the allograft is essential for successful orthotopic liver 
transplantation (OLTx). Primary graft nonfunction 
(PGNF) is associated with an urgent need for retransplan-
tation and, at one time, was associated with an 80 % mor-
tality rate [13]. In order to maximally utilize the limited 
number of liver allografts and to avoid PGNF, it is ex-
tremely important to assess the viability of the hepatic al-
lograft prior to the actual transplant procedure. However, 
little is known about a useful and practical technique that 
can reliably predict allograft viability prior to OLTx. In 
acute and chronic liver diseases, the decreased plasma ac-
tivity of lecithin: cholesterol acyltransferase (LCAT) has 
been well documented [3, 15]. We have recently reported 
that the plasma LCAT activity of the recipient immedi-
ately after OLTx is a reliable indicator of allograft func-
tion in clinical OLTx [14]. The purpose of this study was to 
evaluate, in multiple organ donors, the significance of 
plasma LCAT activity as an indicator of hepatic allograft 
viability prior to OLTx. 
Materials and methods 
During a 5-month period between 1 April and 30 August 1988, 180 
hepatic allografts were transplanted at the Presbyterian University 
Hospital at the University of Pittsburgh. Of these, donor blood was 
available in 39 donors. The selection was made at random and based 
primarily on the cooperation of eight donor surgeons rather than on 
the condition of the donors. The age of the 39 donors ranged from 12 
to 42 years with a mean (± SD) of 24.1 ± 8.4 years. Twenty-six of the 
donors were male (67 %). The causes of brain death among the do-
nors studied were: closed head injury (n = 21; 54 %), gunshot wound 
(n = 9; 23 %), subarachnoid hemorrhage (n = 5; 13 %), and other 
(n = 4; 10 %). Allograft hepatectomy was performed using a rapid 
perfusion technique, or its minor modification with hilar dissection, 
prior to the aortic crossclamp [16,21]. The hepatic allograft was 
flushed through portal and aortic cannulae with chilled, lactated 
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sis of early post-transplant allograft function was performed in 31 of 
the 39 patients (79 %) from whom complete donor information was 
obtained. Computations werc carried out using the statistical soft-
ware "SAS LOGlST" on an IBM system 4381 computer [12] . 
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Fig. I. Correlation between the plasma LCAT activity in multi-
organ donors and early post-transplant allograft function. The 
LCAT activity of the donors of grafts with good function 
(16.4 ± 8.3 )lglml per hour) was significantly higher than that of those 
with fair (8.6 ± 4.5 )lglml per hour, P < 0.01) or poor function 
(7.3 ± 2.4 )lglmL P < O.ol). LeAT Lecithin: cholesterol acyltransfer-
ase (normal range: 20-50 )lglml per hour) 
tion of circulation and then excised following cardiectomy. The allo-
graft was then perfused with two liters of UW solution through the 
portal vein and hepatic artery at a 9: 1 ratio and stored cold in 
UW solution (4'C). 
Donor variables evaluated included age, sex, conventional liver 
function tests [serum glutamic-oxaloacetic transaminase (SGOT), 
scrum glutamic-pyruvic transaminase (SO PT), serum total bilirubin, 
and prothrombin time], arterial blood gases (lowest p02, highest 
pC02, and worst pH), blood pressure (lowest systolic pressure), 
cause of death, graft ischemic time, duration of hospital stay, and his-
tory of cardiac arrest. Pertinent recipient variables evaluatcd in-
cluded age. sex. intraoperative blood loss, and early post-transplant 
liver functions (SOOT, SOPT, serum total bilirubin, and prothrom-
bin time). For the classification of early allograft function, we used 
criteria described in the past [9, 14, 21]. According to the highest 
SOOT, SOPT, and prothrombin time within 5 days following OLTx. 
early post-1.ransplant allograft function was classified as either good, 
fair, or poor (Table 1). Orafts were classified into the lowest 
(poorest) category into which any of the assessment values fell. 
Blood samples from the donor were drawn through a portal can-
nula in a heparinized sterile tube immediately prior to the aortic 
crossclamp and were stored cold (4 'C) overnight. From these cold-
stored samples, the plasma was separated by centrifugation at 
2000 rpm for 5 min and then stored at - 60 'c. Blood samples from 
nine healthy male volunteers were obtained by phlebotomy and 
used as controls. Plasma LCAT activity was determined using a 
LCAT test kit-S (Nippon Shoji, Osaka, Japan) and a spectro-
photometer with a modification of the method described by Naga-
saki and A kamuma [10]. A unit of LCAT activity was defined as the 
ability to esteri Cy Cree cholesterol at 3TC ()lglml per hour) in the 
assay mixture. 
Thirty-threc allograft biopsies were obtained using a Trucut 
biopsy needle (Travenol Laboratories, Deerfield, Illinois. USA) 
immediately prior to implantation. 
The grafts were followed lor up to 1 month after OLTx. Two 
grafts in the poor function group were lost due to pancreatitis and re-
jection, respectively, and the other grafts were functional I month 
after OLTx. 
Statistical analysis was by Wilcoxon's rank-sum test. The results 
are expressed as mean ± SD. The multiple logistic regression analy-
LCAT activity in the multiple organ donors was signifi-
cantly lower than that in the healthy controls (12A ± 8.0 vs 
39.2 ± 13.3 /-lg/ml per hour, P < 0.01). Figure 1 demon-
strates the correlation between plasma LCAT activity of 
mUltiple organ donors and early post-transplant allograft 
function. The LCAT activity of the donors of grafts with 
good function (16A ± 8.3 /-lg/ml per hour) was significantly 
higher than that of those with fair (8.6 ± 4.5 /-lg/ml per 
hour, P < 0.01) or poor (7.3 ± 2A /-lg/ml per hour, P < 0.01) 
function. 
Table 2 shows the results of univariate analysis on the 
correlation between donor variables and early post-trans-
plant allograft function following OLTx. The donor age of 
the grafts with fair function was higher than that of those 
with good function (29.7 ± 7.6 vs 22A ± 7.8 years, 
P < 0.05). The stay in the intensive care unit (lCU) of do-
nors with fair grafts was also longer than those with good 
grafts (6.6±3.9 vs 2A± 1.8 days, PdlOl). Other donor 
variables were comparable. Table 3 demonstrates the 
correlation between post-transplant allograft function 
and graft ischemic time or clinical recipient variables. The 
estimated operative blood loss of poor grafts was signifi-
cantly lower than that of good grafts (6.8 ± 6.0 vs 
17.8 ± 18.9, P < 0.05). Other variables did not show signi-
ficant differences. 
Six of 33 biopsies (18.2 %) exhibited varying degrees of 
microscopic steatosis. The LCAT activity of the donors 
Table 1. Classification of early post-transplant allograft function. 
OLTx, Orthotopic liver transplantation; PT, prothrombin time 
Variable" Early allograft function 
Good Fair Poor 
SGOT (IUII) ::; 1500 ::;3500 >3500 
SOPT (IUII) ::; 1000 ::; 2500 > 2500 
PT (sec) ::;20.0 ::;20.0 >20.0 
a Data were collected within 5 days after OLTx 
Table 2. Univariate analysis on the correlation between donor vari-
ables and early allograft function following OLTx. OLTx, Ortho-
topic livcr transplantation; lCU, intensive care unit; T.Bil, serum 
total bilirubin; PT, prothrombin time 
Variable 
Age (years) 






b P< 0.05 
, P<O.01 
Early allograft function 
Good Fair 
(n = 22) (n = 7) 
22.4 ± 7.8"b 
2.4 ± 1.8' 
77.1 ± 54.1 
53.3 ± 54.0 
0.9± 0.6 
13.2 ± 1.8 
29.7 ± 7.6b 
6.6 ± 3.9' 
48.6± 44.6 
47.0 ± 42.5 
1.0 ± 0.5 
12.5 ± 1.0 
Poor 
(n = 10) 
24.0 ± 9.4 
3.5 ± 2.5 
86.6 ± 59.6 
47.1 ± 36.2 
0.6 ± 0.3 
13.5 ± 2.1 
Table 3. Correlation between early post-transplant allograft func-






Early post-transplant allograft function 
Good Fair Poor 
(/1 = 22) (/1 = 7) (/1 = 10) 
830 ± 327" 
39.8 ± 13.6 
17.8± 18.9b 
685 ± 321 
19.4± 11.6 
9.9±5.3 
766 ± 291 
43.3 ± 13.9 
6.8 ± 6.0b 
a Mean ± SD b P < 0.02 
Table 4. Multivariate analysis on thc correlation between donor 
variablcs and post-transplant allograft function. LCAT, Leci-
thin: cholesterol acyltransferase; T.Bil, scrum total bilirubin; PT, 
prothrombin time; ICU, intensive care unit 
Variable Coefficien t SE Pvalue 
LCAT -0.164 0.287 0.Q18 
T.Bil - 3.136 2.001 0.117 
Histology 2.587 1.781 0.146 
SGOT 0.009 0.011 0.398 
Age (U)76 0.113 0.50U 
PT 0.234 0.350 0.504 
Death 0.330 0.682 0.628 
Sex 0.868 0.682 0.669 
ICU stay -o.om 0.244 0.990 
Constant 1.622 
with steatitic grafts tended to be lower than that of those 
without steatosis (8.4 ± 4.3 vs 13.8 ± 8.8 Ilg/ml per hour). 
As shown in Table 4, the multivariate analysis of the 
donor variables evaluated revealed that plasma LCAT ac-
tivity was the only discriminating factor of allograft via-
bility; the other variables - age, sex, cause of death, dura-
tion of ICU stay, SGOT, prothrombin time, serum total 
bilirubin. and biopsy findings - failed to achieve statisti-
cally significant differences. 
Discussion 
Recently. hyperacute rcjection of the hepatic graft has 
been suggested to be a cause of the primary nonfunction-
ing graft [1. 4J. However, [or a reliable assessment of the 
quality of the donor liver, factors in the recipient, such as 
hyperacute rejection, should be excluded. We therefore 
excluded donors with primary nonfunctioning grafts from 
this study. 
Different variables have been studied with regard to 
the post-transplant assessment of the hepatic allograft, 
including prothrombin time, free amino acid clearance 
[2, 5J, recovery of adenosine triphosphate (ATP) [71 or 
ketone body ratio [19]. and whole body oxygen consump-
tion [17]. We have recently reported that plasma LCAT 
activity following OLTx is a reliable indicator of allograft 
viability [ 14 J. 
The prediction of allograft quality prior to actual trans-
plantation has, however. been less promising. In 1987. 
Makowka et al. [9] reported that none of the currently 
available donor variables could predict graft outcome 
following OLTx. To evaluate the viability of liver allo-
grafts prior to OLTx, Lanir et al. [8] demonstrated in 1988 
29 
that allografts with an ATP level over 2 nmollmg protein 
and with an energy charge over 0.3 could predict the suc-
cessful outcome of OLTx. Kamiike et aI. [7], in 1988, also 
described three grafts with low levels of total adenine nu-
cleotides (TAN) that failed to function and suggested that 
the allograft TAN level before recirculation might corre-
late with the viability of the hepatic allografts. Yet, neither 
of these techniques safely allows evaluation of the allo-
grafts before laparotomy of the donors, since the mea-
surement of adenine nucleotide levels requires liver 
tissue. Moreover, these techniques require special equip-
ment for the determination of adenine nucleotides. It 
seems unlikely that these techniques can be applied clini-
cally at the present time. 
Oellerich et al. [11] reported in 1989 that the formation 
of monoethyl glycinexylidine, after an intravenous injec-
tion of 1 mg/kg lidocaine, correlated well with graft out-
come. This study, however, also required special equip-
ment for the determination of lidocaine metabolites. 
In contrast, LCAT activity can be determined with the 
usc of a simple spectrophotometer and a commercially 
available test kit, which has already been used clinically 
after hepatic resections and other surgical procedures for 
esophageal varices [18]. 
I n the correlation between LCAT activi ty in the donors 
and histology of the biopsies obtained prior to OLTx, allo-
grafts with steatosis tended to have lower plasma LCAT 
activities. These findings seem to reinforce the reliability 
of plasma LCAT activity in multiple organ donors as an 
indicator of liver allograft viability. 
With regard to the significant difference in LCAT ac-
tivity between the group with good function and the 
healthy volunteers, most donors had either cardiac arrest, 
hypotension, or poor nutritional support, and the initial 
management of patients with severe brain injury is fo-
cused on keeping patients dry to prevent brain edema 
rather than on maintenance of abdominal visceral perfu-
sion. As a result, LCAT activities of the donors, even in 
the group with good function. was lower than that of 
healthy volunteers. 
As for the higher estimated intra-operative blood loss 
of recipients of good grafts than those of poor grafts, this 
contradictory finding would appear to be explained by 
massive blood loss (39-63 Ilg/ml per hour) due to techni-
cal failure in four patients who received good grafts and 
who probably raised the mean value of blood loss. 
In summary, plasma LCAT activity in multiple organ 
donors seems to be a discriminating and practical predic-
tor of human liver allograft viability prior to actual OLTx. 
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